BioTelemetry

The healthcare industry is at a critical juncture, where every effort is being made to increase the effectiveness of care, while decreasing the financial burden on our system. With the introduction of BioTelemetry, we aim to lead in the advancement of mobile health monitoring by providing unmatched products and services to help healthcare professionals track and diagnose patients in a more efficient, accurate, and cost-effective manner. In April 2013, our predecessor company, CardioNet, Inc. (NASDAQ: BEAT), announced plans to adopt a holding company structure to more effectively facilitate our ongoing growth plans. With this change, our strategy is to achieve sustained long-term growth by solidifying our leadership position in remote cardiac monitoring, building a leading research services business, and identifying markets that would benefit from the application of our wireless platform and proprietary technology. We currently have four subsidiaries: CardioNet & Mednet- cardiac medical device & monitoring services, Braemar- cardiac manufacturing, Cardiocore- cardiac clinical research.
Type
Public
HQ
Malvern, US
Founded
2013
Employees
938 (est)
BioTelemetry was founded in 2013 and is headquartered in Malvern, US

BioTelemetry Locations

Malvern, US

BioTelemetry Metrics

BioTelemetry Summary

Market capitalization

$580 M

Closing share price

$20.6
BioTelemetry's latest market capitalization is $580 M.

BioTelemetry Financials

BioTelemetry's revenue was $130 M in FY, 2013 which is 16.15% increase from the previous period.
FY, 2011FY, 2012FY, 2013

Revenue

$119 M$111 M$130 M

Cost of goods sold

$6.25 M$5.07 M$4.94 M

Gross profit

$113 M$106 M$125 M

Gross profit Margin, %

94.8%95.4%96.2%

BioTelemetry Market Value History

BioTelemetry News

BioTelemetry Company Life

You may also be interested in